// App-Quantinova.ai

Filters

Biomarkers











Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease











Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























7277 Abstracts

Everolimus-eluting bioabsorbable vascular scaffold and personalised platelet inhibition: no scaffold thrombosis in a single-centre registry with 223 consecutive patients

Christ G - European Association of Percutaneous Cardiovascular Intervention (EuroPCR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Everolimus

Angiographic and clinical outcomes of patients treated with everolimus-eluting bioresorbable stents in routine clinical practice - Results of the ISAR-ABSORB Registry

Hoppmann P - European Association of Percutaneous Cardiovascular Intervention (EuroPCR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Venous thrombosis

Everolimus

Use of Absorb bioresorbable scaffolds for the treatment of coronary ostial lesions - Results from the GHOST-EU database

Gori T - European Association of Percutaneous Cardiovascular Intervention (EuroPCR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Venous thrombosis

Everolimus

Novolimus-eluting bioresorbable scaffolds in the treatment of coronary artery disease: first results from an all-comers population

Wiebe J - European Association of Percutaneous Cardiovascular Intervention (EuroPCR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Venous thrombosis

N/A

Outcome after percutaneous treatment of chronic total occlusions with bioresorbable scaffolds

Trobs M - European Association of Percutaneous Cardiovascular Intervention (EuroPCR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Everolimus

Clinical outcomes following off-label use vs. established indications of bioresorbable scaffolds in a real-world population

Miyazaki T - European Association of Percutaneous Cardiovascular Intervention (EuroPCR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Venous thrombosis

Everolimus

OCT guided bioresorbable vascular scaffold implantation is associated with low rates of scaffold malapposition and early neointimal strut coverage: potential for reduction of scaffold thrombosis

Giblett J - European Association of Percutaneous Cardiovascular Intervention (EuroPCR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Safety and efficacy of everolimus-eluting bioresorbable scaffolds in complex coronary lesions

De Waha S - European Association of Percutaneous Cardiovascular Intervention (EuroPCR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Venous thrombosis

Everolimus

Clinical outcomes of patients with long lesions treated with everolimus-eluting bioresorbable vascular scaffolds: a subgroup analysis from a single-centre all-comers absorb registry

Camacho Freire S.J - European Association of Percutaneous Cardiovascular Intervention (EuroPCR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Everolimus

Fremantle experience of patients undergoing bioresorbable vascular scaffold implantation

Rehmani A - European Association of Percutaneous Cardiovascular Intervention (EuroPCR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Patient and lesion characteristics of acute bioresorbable vascular scaffold thrombosis

Schlundt C - European Association of Percutaneous Cardiovascular Intervention (EuroPCR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Everolimus

Safety of bioresorbable vascular scaffolds in the treatment of acute coronary syndrome: experience in our hospital

Roa-Garrido J - European Association of Percutaneous Cardiovascular Intervention (EuroPCR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Bioresorbable vascular scaffold system: a single-centre experience

Ozel E - European Association of Percutaneous Cardiovascular Intervention (EuroPCR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Venous thrombosis

N/A

Twelve-month outcomes with bioresorbable vascular scaffolds in real world coronary disease

Robaei D - European Association of Percutaneous Cardiovascular Intervention (EuroPCR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Venous thrombosis

Clopidogrel bisulfate

Five-year experience with the Absorb bioresorbable vascular scaffold: the Maasstad Absorb registry

Vlachojannis G.J - European Association of Percutaneous Cardiovascular Intervention (EuroPCR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Venous thrombosis

Everolimus

Safety and efficacy of overlapping everolimus-eluting bioresorbable scaffolds

De Waha S - European Association of Percutaneous Cardiovascular Intervention (EuroPCR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Venous thrombosis

Everolimus

The effect of the choice of contrast media on MARCE events in angioplasty procedures

Mallow P - European Association of Percutaneous Cardiovascular Intervention (EuroPCR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

Iopromide

Indications and immediate and long-term results of a novel pericardium covered stent graft: consecutive 5-year single-centre experience

Di Mario C - European Association of Percutaneous Cardiovascular Intervention (EuroPCR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

The safety and efficacy of full metal jacket with second generation drug-eluting stents for chronic total occlusion

Honda Y - European Association of Percutaneous Cardiovascular Intervention (EuroPCR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

ZoMaxx

Zotarolimus-eluting vs. bare-metal stent in high bleeding risk patients undergoing a 30-day intended duration of dual antiplatelet therapy A pre-specified analysis from the Zotarolimus-eluting Endeavor sprint stent in Uncertain DES candidates (ZEUS) study

Ariotti S - European Association of Percutaneous Cardiovascular Intervention (EuroPCR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

ZoMaxx

Copyright © 2026. QuantiNova All rights reserved